Torthaí cuardaigh - Annette Duck
- 1 - 5 toradh as 5 á dtaispeáint
-
1
IPF Care: A Support Program for Patients with Idiopathic Pulmonary Fibrosis Treated with Pirfenidone in Europe de réir Annette Duck, Lucy Pigram, Peter Errhalt, Deeba Ahmed, Nazia Chaudhuri
Foilsithe / Cruthaithe 2015Revisão -
2
Real world experiences: Pirfenidone is well tolerated in patients with idiopathic pulmonary fibrosis de réir Nazia Chaudhuri, Annette Duck, Rebecca Frank, Jayne Holme, Colm Leonard
Foilsithe / Cruthaithe 2013Artigo -
3
Ambulatory oxygen in idiopathic pulmonary fibrosis: of what benefit?: Table 1– de réir Rebecca Frank, Sophie Hicks, Annette Duck, Lisa Spencer, C.T. Leonard, Emma Barnett
Foilsithe / Cruthaithe 2012Carta -
4
Perceptions, experiences and needs of patients with idiopathic pulmonary fibrosis de réir Annette Duck, Lisa Spencer, Simon Bailey, C.T. Leonard, Jennifer Ormes, Ann‐Louise Caress
Foilsithe / Cruthaithe 2014Artigo -
5
European IPF Patient Charter: unmet needs and a call to action for healthcare policymakers de réir Francesco Bonella, Marlies Wijsenbeek, María Molina‐Molina, Annette Duck, Rosalba Mele, Klaus Geißler, Wim Wuyts
Foilsithe / Cruthaithe 2015Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Medicine
Idiopathic pulmonary fibrosis
Intensive care medicine
Internal medicine
Lung
Adverse effect
Business
Discontinuation
Environmental health
Life expectancy
Marketing
Nursing
Pirfenidone
Population
Pulmonary fibrosis
Quality of life (healthcare)
Action (physics)
Ambulatory
Call to action
Charter
Clinical psychology
Computer science
Coping (psychology)
Data mining
Disease
Family medicine
Fibrosis
Focus group
Health care
Interstitial lung disease